Richen innovative

Richen innovative

Richen innovative drug research and development platform is a comprehensive probe drug research and development platform based on stable isotope (13C, 18O, etc.) labeling and gas analysis and diagnosis. Screening and verification of disease-related molecular markers, probe drug design and synthesis, structural and functional analysis, pharmacy and preclinical research; continuous improvement of drug registration and production processes, providing safe, convenient, accurate and efficient diagnostic drugs for clinical use.
Richen innovative drug research and development platform has the 13C Breathing Test New Drug Technology Beijing Engineering Laboratory approved and supported by the Beijing Municipal Development and Reform Commission; it has a chemical synthesis laboratory, an analytical testing laboratory, a formulation research laboratory, etc.; Advanced equipment such as gas chromatography, liquid chromatography, GC-MS, and Fourier infrared spectrometer; it has a high-level technical team led by returned overseas experts and Ph.D.
Richen innovative drug research and development platform cooperates with famous universities and research institutions at home and abroad to carry out research on molecular mechanism and technology of breath diagnosis in the fields of human metabolomics and volatile organic compounds, and continuously innovate and develop new probe drugs.